Zuoli Pharmaceutical: Net profit in the first half of 2025 was 374 million yuan, an increase of 26.16% year-on-year.

Sali Pharmaceutical announced that its operating income in the first half of 2025 was 1.599 billion yuan, a year-on-year increase of 11.99%. The net profit was 374 million yuan, a year-on-year increase of 26.16%.